Related Experiment Video
Updated: Aug 1, 2025

An Orthotopic Murine Model of Human Prostate Cancer Metastasis
Published on: September 18, 2013
Sulforaphane and Its Protective Role in Prostate Cancer: A Mechanistic Approach
James Mordecai1, Saleem Ullah2, Irshad Ahmad1,3
1Department of Bioengineering, King Fahd University of Petroleum and Minerals (KFUPM), Dhahran 31261, Saudi Arabia.
Abstract:
The increasing incidence of prostate cancer worldwide has spurred research into novel therapeutics for its treatment and prevention. Sulforaphane, derived from broccoli and other members of the Brassica genus, is a phytochemical shown to have anticancer properties. Numerous studies have shown that sulforaphane prevents the development and progression of prostatic tumors. This review evaluates the most recent published reports on prevention of the progression of prostate cancer by sulforaphane in vitro, in vivo and in clinical settings. A detailed description of the proposed mechanisms of action of sulforaphane on prostatic cells is provided. Furthermore, we discuss the challenges, limitations and future prospects of using sulforaphane as a therapeutic agent in treatment of prostate cancer.
Insights
Sulforaphane, a compound from broccoli, shows promise in preventing prostate cancer progression. This review covers its anticancer effects and mechanisms in various settings, offering insights for future therapeutic use.
Area of Science:
- Oncology
- Nutritional Science
- Phytochemistry
Background:
- Prostate cancer incidence is rising globally.
- Sulforaphane, a phytochemical from Brassica vegetables, exhibits anticancer properties.
- Existing research indicates sulforaphane's potential in preventing prostate tumor development and progression.
Purpose of the Study:
- To review recent findings on sulforaphane's role in preventing prostate cancer progression.
- To detail the proposed mechanisms of action of sulforaphane.
- To discuss challenges and future prospects for sulforaphane as a prostate cancer therapeutic.
Main Methods:
- In vitro studies
- In vivo studies
- Clinical trials
- Literature review of recent publications
Main Results:
- Sulforaphane demonstrates efficacy in preventing prostate cancer progression across in vitro, in vivo, and clinical models.
- Multiple mechanisms of action are proposed for sulforaphane's effects on prostate cells.
- Evidence supports sulforaphane's potential as a preventative and therapeutic agent.
Conclusions:
- Sulforaphane is a promising agent for prostate cancer prevention and treatment.
- Further research is needed to overcome challenges and optimize its therapeutic application.
- Future prospects include integrating sulforaphane into prostate cancer management strategies.
More Related Videos
Related Concept Videos
Cancer Prevention
Some...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Targeted Cancer Therapies
There are several types of targeted therapies against...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

